The pathogenesis of atherosclerosis: a critical evaluation of the evidence

William E Stehbens1

  • 1Department of Pathology, Wellington School of Medicine, Wellington, New Zealand.

Insights

Hemodynamics, not diet, drives atherosclerosis. Mechanical stress from blood flow causes bioengineering fatigue in artery walls, leading to lesion development and complications like tears and aneurysms.

Area of Science:

  • Cardiovascular Science
  • Biomedical Engineering
  • Pathology

Background:

  • Current atherosclerosis hypotheses often overlook the role of hemodynamics.
  • Existing theories struggle to explain lesion topography, progression, and specific complications.

Purpose of the Study:

  • To establish hemodynamics as the primary driver of atherosclerosis.
  • To elucidate the role of mechanical stress and bioengineering fatigue in disease pathogenesis.

Main Methods:

  • Analysis of lesion topography, transmural involvement, and progression rates.
  • Evaluation of iatrogenic atherosclerosis in grafts and shunts.
  • Comparison of morphological features with metabolic lipid disorders.

Main Results:

  • Consistent lesion patterns strongly implicate hemodynamics.
  • Accelerated atherosclerosis in grafts/shunts confirms the role of disturbed flow.
  • Morphology aligns with mechanical fatigue, not lipid storage disorders.
  • Lipid accumulation and thromboembolism are secondary to fatigue-induced mural failure.

Conclusions:

  • Atherosclerosis is a response to hemodynamically induced tensile stresses and vibrations, causing bioengineering fatigue.
  • This fatigue leads to molecular fragmentation, free-radical formation, and tissue repair.
  • Primary complications arise from fatigue-predominant mural failure; lipid accumulation is secondary.
  • Hemodynamic manipulation in experimental models proves the causal role of fatigue.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
799
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Inflammation01:38

Inflammation

Overview
65.3K